Vanguard Group Inc. raised its stake in shares of Addus HomeCare Corporation (NASDAQ:ADUS – Free Report) by 0.8% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,308,605 shares of the company’s stock after buying an additional 10,501 shares during the quarter. Vanguard Group Inc. owned about 0.07% of Addus HomeCare worth $140,531,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds also recently modified their holdings of the company. Capital Research Global Investors grew its position in shares of Addus HomeCare by 9.0% in the 3rd quarter. Capital Research Global Investors now owns 1,201,560 shares of the company’s stock valued at $141,772,000 after purchasing an additional 99,262 shares during the period. 8 Knots Management LLC acquired a new position in shares of Addus HomeCare during the 3rd quarter worth approximately $6,075,000. Adage Capital Partners GP L.L.C. bought a new stake in shares of Addus HomeCare during the 2nd quarter worth approximately $4,838,000. Punch & Associates Investment Management Inc. lifted its stake in Addus HomeCare by 29.1% in the third quarter. Punch & Associates Investment Management Inc. now owns 143,655 shares of the company’s stock valued at $16,950,000 after acquiring an additional 32,355 shares during the last quarter. Finally, Raymond James Financial Inc. increased its holdings in shares of Addus HomeCare by 5,969.5% during the 3rd quarter. Raymond James Financial Inc. now owns 32,047 shares of the company’s stock worth $3,781,000 after acquiring an additional 31,519 shares during the last quarter. 95.35% of the stock is owned by institutional investors.
Addus HomeCare Stock Down 1.8%
NASDAQ:ADUS opened at $97.79 on Tuesday. Addus HomeCare Corporation has a one year low of $90.89 and a one year high of $124.43. The company has a debt-to-equity ratio of 0.08, a current ratio of 1.83 and a quick ratio of 1.83. The company has a market cap of $1.83 billion, a PE ratio of 18.08, a P/E/G ratio of 1.37 and a beta of 0.92. The firm’s 50 day simple moving average is $97.57 and its 200 day simple moving average is $107.07.
Analyst Upgrades and Downgrades
A number of equities research analysts have recently weighed in on ADUS shares. Citizens Jmp dropped their target price on Addus HomeCare from $150.00 to $142.00 and set a “market outperform” rating for the company in a report on Wednesday, May 6th. Barclays cut their price objective on shares of Addus HomeCare from $112.00 to $102.00 and set an “underweight” rating for the company in a research report on Wednesday, March 25th. Weiss Ratings reissued a “hold (c+)” rating on shares of Addus HomeCare in a report on Wednesday, January 21st. Royal Bank Of Canada restated an “outperform” rating and issued a $139.00 target price on shares of Addus HomeCare in a research report on Wednesday, February 25th. Finally, KeyCorp reiterated an “overweight” rating on shares of Addus HomeCare in a research report on Wednesday, February 25th. One equities research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $132.33.
View Our Latest Stock Analysis on Addus HomeCare
Insider Transactions at Addus HomeCare
In other news, EVP Darby Anderson sold 733 shares of the stock in a transaction on Tuesday, February 24th. The shares were sold at an average price of $106.98, for a total transaction of $78,416.34. Following the completion of the sale, the executive vice president directly owned 46,642 shares in the company, valued at $4,989,761.16. This represents a 1.55% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, CEO R Dirk Allison sold 4,988 shares of the business’s stock in a transaction on Tuesday, February 24th. The shares were sold at an average price of $106.98, for a total transaction of $533,616.24. Following the completion of the transaction, the chief executive officer owned 185,514 shares in the company, valued at approximately $19,846,287.72. The trade was a 2.62% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders have sold 16,788 shares of company stock worth $1,785,633. Company insiders own 4.50% of the company’s stock.
Addus HomeCare Company Profile
Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.
The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.
Featured Articles
- Five stocks we like better than Addus HomeCare
- Sell in May and Go Away—Starting With These 3 Stocks
- Before the Moon Base Gets Built, These 4 Companies Win
- Industrial Buybacks: Top Homebuilding Supplier Leads Buyback Increases
- 3 Stocks That Win If Inflation Surprises to the Downside
Want to see what other hedge funds are holding ADUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Addus HomeCare Corporation (NASDAQ:ADUS – Free Report).
Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.
